Ethosomal nanocarrier encapsulating curcumin for antimicrobial photodynamic therapy: efficacy analysis against mature Streptococcus mutans biofilm Authors: Alireza Partoazar, Sima Shahabi, Shima Afrasiabi Published: 2026 ABSTRACT AbstractBackgroundBiofilms contribute to the dental calculus formation, which in turn deteriorates oral and systemic health. The use of antimicrobial photodynamic therapy (PDT) may be limited by problems with photosensitizer penetration. In addition, toxicity issues severely limit the potential of PDT. In this study, the selected photosensitizer, curcumin (Cur), was loaded into ethosome (Eth) nanocarriers to enhance the effect of Cur for potential PDT against the mature Streptococcus mutans biofilm.MethodsThe Cur-Eth formulation was characterized and evaluated for its PDT efficacy in destroying the mature S. mutans biofilm. Colorimetric and confocal microscopy assay were used for this purpose. Cur in free and ethosomal form was also evaluated for in vitro cytotoxicity study on human gingival fibroblasts (HGFs) by MTT assay.ResultsThe formulation has spherical structures with a mean vesicle size of 191.3 ± 6.5 nm and an EE of 87.32 ± 1.43%. Cur-Eth showed good biocompatibility, which was confirmed by the cellular viability of HGFs. Photoactivated Cur-Eth showed 39.62 ± 8.50% reduction in mature S. mutans biofilm (P < 0.001), which was not a significant difference compared to 5% sodium hypochlorite (NaOCl) with 49.52 ± 0.23% reduction (P = 0.608). In addition, confocal microscopy showed cell disintegration of Cur-Eth after LED irradiation.ConclusionThe present study provides a strong rationale and motivation for further investigation of Eth as a potential therapeutic strategy, especially in the case of older biofilms.Keywords: Biofilms, Curcumin, Dental plaque, Drug delivery, Ethosomes, Nanocarriers, Photochemotherapy Introduction The bacterial composition of dental plaque is relatively stable and forms mainly in areas that are protected from plaque-removing forces such as tooth brushing [1]. When plaque remains, it hardens and forms calculus above and below the gingival margin, triggering an inflammatory response from the host and excessive flow of gingival crevicular fluid that can lead to gingival recession, periodontal disease, periodontal pus overflow, root exposure and tooth loss, which are inevitable in advanced stages of periodontitis [2]. The treatment of deep carious lesions in vital, asymptomatic teeth is challenging. Complete removal of carious tissue is a common dental procedure but poses a serious challenge in deep carious lesions due to the risk of exposing the pulp. This exposure may require invasive and complex treatments such as pulpectomy or tooth extraction, which are painful and potentially damaging. In addition, these treatments are financially costly and require repeated follow-up visits [3]. Streptococcus mutans is considered to be the most important bacterium in causing dental caries. When S. mutans comes into contact with saliva and nutrient-rich foods, it metabolizes carbohydrates and produces acid. Extracellular polysaccharides (EPS), which are produced to adhere to tooth surfaces, can facilitate the adhesion of other pathogenic bacteria. By forming biofilms, S. mutans creates a stable harbor for bacteria, making them difficult to remove. The acids produced by the bacterial metabolic activity within the biofilm degrade hydroxyapatite, a key component of tooth enamel, leading to enamel demineralization and the occurrence of caries [4]. The importance of biofilm age and nutrition for biofilm behavior was demonstrated by Stojicic et al. They found that biofilms that are two weeks old are more sensitive to the factors tested than biofilms that have grown for three weeks or longer [5]. The results of the various studies cannot easily be compared or correlated with real clinical situations. In most studies, biofilms were cultured for only 1 to 7 days, while longer periods were used only occasionally [6]. The biofilm model used in this study promotes the EPS formation as the biofilm grows in a carbohydrate-rich diet for three weeks, ultimately leading to thicker biofilms. Antimicrobial photodynamic therapy (PDT) allows the inactivation of bacteria through the generation of local reactive oxygen species (ROS) and has been considered in recent years as a complementary strategy for the control of oral biofilms. However, the efficacy of PDT in mature biofilms is limited. The main reason is insufficient penetration of the photosensitizer and light sources [7]. The short lifespan of the ROS and their limited diffusion distance prevent further bacterial eradication [8]. Encouragingly, PDT has met with great interest in the reduction of biofilms. However, the success rate of microbial inactivation is influenced by factors such as light dose, incubation time, and the ability of the photosensitizer to penetrate the target cells, all of which depend on the size, charge, and solubility of the substance [9]. The lack of improvement in bacterial reduction results may require higher photosensitizer concentrations and energy doses, which may be associated with complications [10]. Curcumin (Cur) as a natural photosensitizer has advantages such as low toxicity, anti-inflammatory effect and the ability to generate ROS under appropriate irradiation. Therefore, it is an attractive option for oral PDT. However, limitations such as low aqueous solubility, unstable stability, and limited penetration into the biofilm matrix have prevented its full potential [11]. In this case, drug delivery systems and nano-formulated photosensitizers are also a step forward in photosensitizer development [12–16]. Ethosomes (Eth) are a novel vesicular delivery system characterized by a bilayer lipid structure. This system consists of alcohol, phospholipids, and water, and is known for its high encapsulation efficiency (EE), small particle size, and high stability [17]. Eth with their alcoholic phase and flexible membrane have been shown to enhance the penetration of lipophilic molecules such as Cur into the deep tissue and biofilm matrix [18, 19]. Despite numerous studies on Cur-PDT effect on biofilms, there is limited and conflicting data on its efficacy on old biofilms [20]. In this study, we developed Cur-Eth and investigated its photodynamic effect upon light-emitting diode (LED) irradiation on 21-day-old S. mutans biofilms compared to free Cur. In addition, toxicity in human gingival fibroblasts (HGFs) was compared to assess the local safety of this compound. The aim of this study was to determine whether an ethosomal carrier can improve the penetration and efficacy of Cur-PDT in mature S. mutans biofilm. The null hypothesis of this study was that PDT with Cur-Eth under LED irradiation makes no significant difference in reducing the mature S. mutans biofilm and in cytotoxicity to human gingival fibroblasts compared to free Cur. Materials and methods Drug preparation and characterization The methods of ethanol injection were developed to prepare Cur-Eth according to previous studies [21, 22]. Briefly, 200 mg of soy lecithin (Lipoid, Germany) and 20 mg of cholesterol (Merck, Germany) were mixed with 50 mg of Cur (Sigma, St. Louis, MO) dissolved in DMSO (5% v/v) at 30 °C using a magnetic stirrer. The lipid mixture was carefully added with a syringe to a sealed container containing 10 ml of ethanol (35% v/v) and normal saline and stirred at 700 rpm for 1 h. Then the suspension was extruded repeatedly (at least 8 times) through 200 nm–100 nm polycarbonate membranes at 30 °C. A similar procedure was performed without Cur to produce the corresponding blank-Eth. Moreover, the free form of Cur was prepared by dissolving it in DMSO 5%. EE percentage was determined based on the method with a modification [23]. Briefly, the polycarbonate filters saturated with Cur used for extrusion were immersed in anhydrous methanol. Then the residue dissolved in anhydrous methanol was analyzed using a UV spectrophotometer (Cecil, UK) at 430 nm wavelength. EE percentage was determined as described in the following equation: The dynamic light scattering (DLS) technique using a zetasizer system (HORIBA SZ-100, Japan) was used to determine the mean diameter and surface charge of Cur-Eth. In addition, the morphology of Cur-Eth was imaged using the TEM technique (Zeiss, Germany). Moreover, the release profile of Cur-Eth was analyzed using the Franz diffusion cell method [23]. Briefly, 2 ml of the suspension was added to a donor chamber separated by a 12 kDa cut-off dialysis membrane. Furthermore, the receptor chamber was filled with 70 ml of phosphate-buffered saline (PBS) (pH: 7.4) containing 35% ethanol and stirred continuously at a speed of 100 rpm at 37°. Then, a small volume of the released drug was withdrawn at the specified time points and subsequently the receptor solution was replaced by a corresponding volume of the sample. In the next step, the Cur concentration was measured at 430 nm using a UV spectrophotometer (Cecil, Cambridge, UK). In addition, Cur was dissolved at the same concentration in the formulation in DMSO (5% v/v) and then analyzed under the same conditions to verify that the sustained release profile was due to the formulation. Bacterial strain and culture condition Biofilm activities were evaluated using S. mutans (lBRC-M 10682) cultured overnight in brain–heart infusion broth with 1% (w/v) sucrose (BHIS, Merck, Germany) under aerobic conditions (5% CO2, 10% H2, and 85% N2) at 37 °C. Determination of Minimum Inhibitory Concentration (MIC) In brief, the 0.5 McFarland turbidity standard of S. mutans was diluted 1/100 to obtain 1.5 × 106 CFU ml− 1 in broth medium. Serial twofold dilutions of 10 to 0.078 mg ml− 1 of Cur were prepared and 100 µl of each concentration was added to each corresponding well. The plate is incubated overnight at 37 °C. The MIC is defined as the lowest concentration of Cur that inhibits visible growth of the tested isolate [24]. Determination of Minimum Biofilm Eradication Concentration (MBEC) To determine the MBEC of Cur against S. mutans, the 24-h biofilms were washed in a 96-well microtiter plate with PBS and air-dried. Cur at concentrations of 1 MIC to 8 MIC was added to the corresponding wells. After incubation at 37 °C for 24 h, the culture medium was drained, the pellet was washed with PBS and scraped thoroughly. The pellet was dissolved in 200 µl PBS and then serially diluted suspensions were inoculated onto BHI plates. After 48 h of incubation at 37 °C, colonies were counted and the lowest Cur concentration that inhibited bacterial growth was considered MBEC [25]. Biofilm formation For biofilm formation, static biofilms were grown on the bottom of the wells of a 96-well microplate as attachment surfaces [26]. In brief, an amount of 200 µl of the starting inoculum (1.5 × 106 CFU ml− 1) was incubated in a 96-well microplate and incubated at 37 °C under CO2 conditions (candle jar) for 21 days to achieve mature biofilm formation. The medium was changed regularly every 48 h. Treatment procedure After 21 days, the microplate wells were washed twice with PBS to remove planktonic cells. Mature S. mutans biofilms were treated with Cur, Cur plus LED (Denmate, Taiwan) or treated with Cur-Eth and Cur-Eth plus LED. Mature S. mutans biofilms without any treatment and 5% sodium hypochlorite (NaOCl) were used as negative and positive controls, respectively. The negative and positive controls were exposed to the same incubation conditions and duration as the experimental groups. Blank-Eth was also considered as an experimental group. The final concentrations of Cur corresponded to the MBEC value. One hundred microliters of the four compounds (NaOCl, Eth, Cur, and Cur-Eth) were appended to the microtiter plate and incubated for 5 min at 25 °C in the dark. In the PDT groups, the biofilms were treated with 1 W cm− 2 430–460 nm blue LED (Denmate, Taiwan) at a dose of 60 J cm− 2. The LED was positioned approximately 1 mm above the surface of the microtiter plate to ensure uniform illumination. The LED was placed on the top of the microtiter plate to ensure that the light was not reflected into neighboring sample wells. Each well was irradiated individually to ensure uniform light exposure in all experimental groups. All wells were irradiated with a beam diameter of 8 mm and an irradiation time of 60 s for all experiments [23]. Biofilm measurement The biofilm was quantified using the crystal violet staining method (CV; Merck, Germany) as previously described [27]. After washing all wells of the microplate two times with PBS, biofilms were fixed by adding methanol for 15 min before staining with 0.1% CV (w/v, 105 µl) for 30 min. After CV removal, the wells were washed three times with PBS. The biofilm was solubilized with 70% ethanol (v/v), incubated for 20 min at room temperature with gentle shaking, and quantified by measuring OD595. Confocal laser scanning microscopy (CLSM) analysis Following treatment, samples were subjected to live/dead staining, acridine orange (AO) and propidium iodide (PI). Live and dead cells were visualized by green and red fluorescence, respectively. The sample was then examined using CLSM (Leica TCS SPE, Germany) at 100× magnification. The excitation/emission wavelengths were 488/505 nm for AO and 532/635 nm for PI. MTT assay HGFs were obtained from Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran and cultured in Dulbecco’s modified Eagle’s medium (Ideh Zist, Iran) with 10% fetal bovine serum (Pan Biotech, Germany) and penicillin-streptomycin under 5% CO2 and 95% humidity. Cells were cultured in the 96-well microplate at a density of 10,000 cells per well. After treatment with Eth or Cur (free or trapped in Eth) at the same concentrations as used for the biofilm assay, the cells were evaluated for cytotoxicity after 24 h. To examine cell proliferation, a colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Sigma, Germany) was performed. For this purpose, the culture medium was completely removed from each well and 50 µl of MTT solution (5 mg ml− 1 MTT (Sigma, Germany) was added, followed by incubation for 3–4 h at 37 °C and 5% CO2. Finally, the MTT solution was removed and replaced with 100 µl DMSO. After shaking for 15 min, the absorbance at 570 nm was determined using a microplate reader (BioTek, USA). Proliferation of treated groups was expressed as a percentage of controls [28]. Morphological assessment was examined using an inverted microscope (Olympus IX 70) with 5× magnification. Statistical analysis All quantitative data were expressed as the mean and standard deviation (SD) of each experiment performed in triplicate. The results of all assays were compared using one-way analysis of variance (ANOVA) using Tukey’s test for multiple comparisons with SPSS 26. Values of *P < 0.05 was considered statistically significant. Results Cur-Eth characterization The TEM images show that the Eth have a spherical shape and are uniform with minimal nanoaggregates (Fig. 1a). Furthermore, the DLS analysis in Fig. 1b shows that the Cur-Eth suspension was prepared in a nano-size range with a negative surface charge. The size range of Cur-Eth is 191.3 ± 6.5 nm with a good polydispersity index (0.36 ± 0.15). In addition, the data show that the zeta potential of the prepared Cur-Eth is -23 mV and most of the drug was encapsulated in the Eth with an EE% of 87.32 ± 1.43%. The cumulative drug release (Fig. 1c) of the formulation and the free drug also showed that the Cur molecules were increasingly released into the acceptor medium during the 12-hour incubation at 37 °C. It is noteworthy that the release of the drug in the free form of the drug was significantly higher compared to Cur-Eth at most time intervals. The percent of drug release for Cur-Eth was estimated to be 53.4 ± 1.81, while for the free form of the drug it was 86.1 ± 3.76 at the end of the experiment. The representative characterization of Cur- Eth includes (a) photography of suspension taken by transmission electron microscope (Scale bar: 200 nm); b size and surface charge measured by DLS; c The cumulative release percentage of Cur-Eth compared to the free forms of Cur during the 12 h in vitro evaluation MIC and MBEC determination The MIC value of Cur for S. mutans suspension was 2.5 mg ml− 1. The cell viability decreased in a dose-dependent manner, so that significant inhibitory effects on the growth of the S. mutans suspension occurred at concentrations of 2.5 to 10 mg ml− 1 (P < 0.05). The MBEC value of Cur was 5 mg ml− 1, which was 2-fold higher than the MIC. Anti‑biofilm effects As shown in Fig. 2, after NaOCl treatment, there was a strong reduction in mature S. mutans biofilm (49.52 ± 0.23%, P < 0.001). After PDT, Cur-Eth significantly reduced the mature S. mutans biofilm compared to the control group (39.62 ± 8.50%, P < 0.001). The biofilm was also reduced in the Cur + LED and Cur-Eth groups (28.56 ± 7.23%, P = 0.005 and 27.88 ± 2.43%, P = 0.006, respectively). Mature biofilm was slightly reduced in the Cur group (14.29 ± 7.08%, P = 0.068). Biofilm reduction in the blank-Eth group was again at the same level as in the control group (4.17 ± 2.39%, P = 0.971). Importantly, no significant difference was observed between the Cur-Eth + LED and NaOCl groups (P = 0.608), while there was a significant difference between Cur + LED and NaOCl groups (P = 0.045). Absorbance values of the biofilm after different treatments. Data are presented as means ± SD (n = 3). *p < 0.05 and **p < 0.001 when compared to control CLSM bacterial viability measurements CLSM analysis confirmed a high number of viable bacterial cells, further confirming the establishment of a mature S. mutans biofilm (Fig. 3a). The Eth group showed a biofilm with a high percentage of viable bacteria (Fig. 3b). CLSM analysis of the NaOCl group showed dead bacterial cells (red) scattered in the remaining biofilm structure (Fig. 3c). The CLSM images show that the bacteria survived in the presence of Cur without irradiation (Fig. 3d). Treatment with Cur + LED effectively killed the bacteria but left a residual biofilm (Fig. 3e). Some red dots can be seen on the CLSM images of Cur-Eth, indicating that the viability of the bacteria was also slightly reduced (Fig. 3f). The Cur-Eth + LED treatment showed the most effective disinfection result, similar to the NaOCl group (Fig. 3g). Fluorescence microscopy imaging of 21-day-old biofilm of Streptococcus mutans, which were incubated with acridine orange and propidium iodide before imaging. a control; b cells treated with Eth; c cells treated with NaOCl; d cells treated with Cur with 5 mg ml-1; e cells treated with Cur + LED; f cells treated with Cur- Eth; g cells treated with Cur- Eth + LED. Scale bar: 10 µm Cell viability Figure 4a shows the dark toxicity test after 24 h of incubation with negative control, blank-Eth, Cur, and Cur- Eth. Figure 4b1 shows the negative control (100 ± 2.45%). As shown in Fig. 4b2,4, the dark toxicity test on HGFs after incubation with blank-Eth and Cur-Eth nanocarriers, both had no significant cellular toxicity (P > 0.05) when compared to control cells (83.57 ± 3.87% and 80.35 ± 3.36%, respectively). The application of Cur to HGFs after 24 h of incubation showed a significant decrease in cell viability. This was observed to be 49.28 ± 1.82% (P < 0.05, Fig. 4b3) at 5 mg ml− 1. a In vitro cytotoxicity effects of blank Eth, Cur, and Cur- Eth on human gingival fibroblasts (HGFs) for 24 h. Significant difference specified as *p < 0.05; b Morphological observation of HGFs by inverted microscope. Photographs of HGFs untreated control cells (b1), cells treated with blank Eth (b2), Cur (b3), and Cur- Eth (b4) for 24 h. Scale bar: 200 µm Discussion The optimization of the intrinsic properties of photosensitizers in terms of high efficacy, safety, better penetration and greater effectiveness against bacteria is considered a fundamental approach to improve PDT [29, 30]. Our data indicate that the Cur-Eth suspension was obtained as nanoscale and monodisperse particles with a high degree of drug encapsulation. It was observed that Eth is composed of phospholipid and ethyl alcohol, which allows better permeability through tissue barriers and better drug loading than conventional delivery systems [19, 31]. The poor solubility of molecules such as Cur requires a suitable formulation like Eth for drug encapsulation and delivery. The unique composition of nano-sized Eth, consisting mainly of phospholipids and a high concentration of ethanol, creates a highly flexible structure that allows various molecules to be efficiently transported through tight barriers such as the stratum corneum [31]. It is hypothesized that Eth may be a promising carrier to penetrate the biofilm structure and kill the bacterial biofilm with the active molecules [32–34]. Moreover, the formulation showed sustained release activity to achieve long-lasting effect and improved bioavailability of the drug. The study on phototherapeutic psoralen, a drug targeting bacterial biofilms, showed a significant bacterial kill of up to 70% and effectively disrupted bacterial adherence in the biofilm [33]. It can be concluded that Cur-Eth can penetrate the EPS structure of the bacterial biofilm and release the cargo near the bacterial cells rather than the free form of the drug. Several studies have investigated the efficacy of Cur-mediated PDT on oral biofilms. A study by Méndez et al. showed that Cur-PDT significantly reduced the viability and survival of microorganisms in dental caries biofilms. However, this study often used young (5-day-old) biofilms or planktonic cells, which are more sensitive to treatment due to their thinner structure and higher metabolic activity [35]. In another study, Cur-based PDT significantly reduced the vitality of the microcosm biofilm during 3 or 5 days. However, a longer pre-irradiation time was required for successful treatment of 5-day biofilms than for their counterparts [36]. In contrast, our study focused on 21-day-old mature S. mutans biofilms, which are more resistant to antimicrobial treatments. There is a decrease in biofilm (∼28%) for the S. mutans biofilm treated with Eth-containing Cur. The bacterial biofilm could be further reduced to ∼40% when the Cur-Eth treated biofilm was irradiated with LED light for 1 min. The results showed that the null hypothesis was rejected. The CLSM analysis supported the quantitative results. The images showed that a biofilm with a high proportion of viable bacterial cells was maintained in the control group and in the Eth group. In contrast, dead bacterial cells were clearly visible within the remaining biofilm structure in the NaOCl group. In the Cur + LED group, although the bacteria were dead, the remaining biofilm structure was still present, suggesting that combined or complementary treatments may be required to achieve complete biofilm removal. It is noteworthy that the Cur-Eth + LED treatment achieved an antibacterial effect comparable to that of NaOCl, a commonly used disinfectant for cavities [37]. The antibacterial effect of Cur-Eth indicates that the ethanol entrapped in the Eth acts as a permeation enhancer, likely through a synergistic interaction between the ethanol-containing vesicles and the bacterial membrane. Cur is known to be poorly soluble in water and tends to aggregate. Its activity is often limited by how well it can reach the bacteria embedded in the EPS matrix. An ethanol-containing vehicle could better dissolve Cur or keep it in a more bioavailable state [38]. Interrupts the hydrophobic interactions in EPS and makes the matrix looser and more permeable. Allows deeper penetration into the biofilm to reach more bacteria. It can also compromise the integrity of bacterial membranes and make them more sensitive to Cur. So, it can cause additive or even synergistic damage. If Eth disrupts the EPS structure or weakens the biofilm matrix, then Cur can reach more cells and more adhesins [33]. Our results show that Cur-Eth exhibits increased permeability because ethanol has a liquefying effect on phospholipid bilayers, which facilitates the penetration of Cur-Eth through the bacterial cell wall [33]. Therefore, Cur-Eth shows more effective photochemical activity in inhibiting bacterial biofilms. These studies on the photoinduced behavior of Cur-Eth as an efficient drug delivery system provide valuable insights for the further development of future photodynamic therapies. Hu et al. demonstrated that a lipid-based nanocarrier such as a liposome can adhere to the S. mutans biofilm and continuously release curcumin to exert antibacterial properties [39]. Wang et al. investigated the use of hexyl aminolevulinate (HAL)-Eth against Propionibacterium acnes biofilms. Their results showed that HAL-Eth had a significant antibacterial effect on P. acnes biofilms [40]. These findings align with our current study that Cur-Eth treatment may be more effective in reducing S. mutans biofilms. Furthermore, they emphasized the importance of nanocarriers in enhancing drug penetration and therapeutic efficacy, which is consistent with our results and highlights the need to develop advanced drug delivery systems [40]. Interestingly, Cur + LED showed less reduction in biofilm compared to Cur-Eth + LED, highlighting the importance of the ethanol carrier in enhancing the penetration of Cur into biofilms. This observation is consistent with the results of Alghamdi et al. who found that ethanol-containing formulations increase the permeability and efficacy of photosensitizers in the treatment of biofilms [33, 41]. Furthermore, while blank Eth and Cur-Eth alone showed some antibacterial activity, their effects were significantly less than when combined with LED, highlighting the role of PDT in maximizing antimicrobial outcomes. Previous reports have shown that light-activated Cur generates ROS, which are responsible for bacterial cell damage [42–44]. This study has shown that Cur-Eth-mediated PDT inhibited the 21-day-old biofilm of S. mutans more compared to Cur-mediated PDT. This could be due to the high ethanol content and small particle size of Eth as a nanocarrier, which enable the drug to efficiently penetrate both the biofilm structure and cell membranes. In addition, PDT can directly damage the biofilm by generating ROS and thus physically disrupting the aggregation of bacterial colonies. Since Cur is lipophilic, it can more easily penetrate through the lipid bilayer, resulting in a stronger photodynamic effect that destabilizes the plasma membrane [34]. The results of MTT assay showed that blank-Eth and Cur-Eth has no cytotoxic effects (> 80% cell viability) on HGFs, indicating their biocompatibility and importance as valuable drug carriers. It was found in the literature that compounds with cell viability greater than 80% are often considered biocompatible [45]. Similar results were shown by Peram et al. who demonstrated that blank-Eth did not cause cytotoxicity in normal mouse fibroblasts or cancer cell lines [46]. The viability of HGFs was drastically reduced after treatment with Cur (~ 50% cell viability) at the same concentration tested. This observation suggests a more pronounced cytotoxic effect of Cur when administered alone than when administered via Eth. At first glance, this may seem contradictory, as Eth is known to enhance permeation and cellular uptake of drugs. However, this discrepancy can be explained by considering the release kinetics and controlled delivery through the ethosomal system. Free Cur is readily available to interact with cells, leading to rapid internalization and cytotoxic effects. In contrast, Cur encapsulated in Eth is released in a more sustained and controlled manner, reducing the immediate intracellular concentration and potential cytotoxicity [47]. In addition, the protective effect of the ethosomal lipid bilayer may help to initially protect cells from the full effects of Cur while improving its stability and bioavailability over time. This controlled delivery may be particularly beneficial in therapeutic applications where a reduction in off-target toxicity is desired [48]. There are some limitations that need to be considered. A limitation of the present study is that architectural parameters such as the average thickness of the biofilms were not evaluated. The inclusion of these analyzes, such as z-stack scanning, would provide complementary insights for spatial analysis and should be considered in future studies. Due to the inherent differences in the physicochemical and photobiological properties of each photosensitizer, this multifactorial concept in dosimetry should be explicitly considered in the planning and execution of all experiments [12, 49]. The experiments were performed exclusively in an in vitro model with S. mutans biofilms produced under controlled laboratory conditions. While this model is valuable for initial evaluations of antimicrobial therapies, it does not fully represent the complexity of biofilms that form in the oral cavity. These typically consist of multispecies communities embedded in a dynamic EPS that interacts with host tissues and immune responses. Future studies should consider testing in more complex biofilm models, including multispecies and saliva-derived biofilms, to better simulate clinical scenarios. We recommend longitudinal studies to evaluate the durability and sustainability of antibacterial effects. Future studies should focus on investigating the precise molecular mechanisms underlying biofilm disruption by these therapies. This includes investigating the effects on gene expression related to biofilm structure and bacterial signaling pathways, which could help refine the design of targeted therapies. The combination of PDT with other antibacterial approaches such as antibiotics, nanoparticle-based antibiotics, or mechanical biofilm removal should be explored to enhance synergistic effects. The development of novel drug carriers with improved biodegradability, higher targeting accuracy, and controlled drug release could significantly enhance the efficacy of PDT. In this regard, the use of nanotechnology is particularly promising. Conclusions In the present study, Cur-Eth was successfully developed to have a suitable nano-sized vesicle shape and good EE. The colorimetric test proved the more effective reduction of the Cur-Eth formulation to pure Cur. The CLSM analysis also confirmed the potential of Eth in destroying the mature biofilm. The MTT assay showed the lower cytotoxic potential of the Cur-Eth formulation compared to Cur in HGFs. These results indicate that Eth may serve as a potential therapeutic strategy with improved pharmacological efficacy and increased safety for the reduction of high-density biofilms. Acknowledgements Not applicable. Clinical trial number Not applicable. Authors' contributions Alireza Partoazar: conceptualization, methodology, writing—original draft preparation. Sima Shahabi: investigation, validation. Shima Afrasiabi: conceptualization, methodology, data curation, supervision, writing—original draft preparation, writing—review and editing. All authors contributed to the article and approved the submitted version. Funding This work was supported by the Dentistry Research Institute, Tehran University of Medical Science & Health Services (no. 1403-3- 234-74454). Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate The study was approved by the ethics committee of Tehran University of Medical Sciences, Tehran, Iran, (IR.TUMS.BLC.1403.101). Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Alireza Partoazar and Sima Shahabi contributed equally to this work. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.